SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016028
Filing Date
2017-08-07
Accepted
2017-08-07 16:34:41
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20170630.htm 10-Q 1908493
2 EX-10.1 atra-ex101_8.htm EX-10.1 103002
3 EX-10.2 atra-ex102_159.htm EX-10.2 92056
4 EX-10.3 atra-ex103_160.htm EX-10.3 76508
5 EX-31.1 atra-ex311_7.htm EX-31.1 14989
6 EX-31.2 atra-ex312_9.htm EX-31.2 15111
7 EX-32.1 atra-ex321_6.htm EX-32.1 7725
  Complete submission text file 0001564590-17-016028.txt   6004812

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT atra-20170630.xml EX-101.INS 1190575
9 XBRL TAXONOMY EXTENSION SCHEMA atra-20170630.xsd EX-101.SCH 34539
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20170630_cal.xml EX-101.CAL 33159
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20170630_def.xml EX-101.DEF 110324
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20170630_lab.xml EX-101.LAB 306749
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20170630_pre.xml EX-101.PRE 221123
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 171011967
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences